US Patent 6946150 Pharmaceutical formulation
Patent 6946150 was granted and assigned to GW Pharma on September, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+607 characters)
Article
Patent abstract
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Brian Whittle0
Date of Patent
September 20, 2005
0Patent Application Number
102189890
Date Filed
August 14, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6946150 Pharmaceutical formulation
Find more entities like US Patent 6946150 Pharmaceutical formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
